Pharm Jan 18, 2007

  • November 2019
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Pharm Jan 18, 2007 as PDF for free.

More details

  • Words: 1,302
  • Pages: 6
Jan 18, 2007  Go to www.naturopathicdoctor.ca/BAS208/ to get notes o Good NPLEX study charts!!!  Autonomic Nervous System o SNS and PNS o Somatic not part of ANS, but put there as a comparison o Fight or flight o SNS o In most case norepiepherine or epinephrine released o Released at adrenergic receptor sites o Alpha 1 and alpha 2 – found in peripheral organs o Beta 1 and beta 2 – found in heart and lungs  Beta 1 in heart (one heart)  Beta 2 in lungs (2 lungs) o SNS  Mostly norepinepherine, except medulla which binds epinephrine and sweat glands where acetylcholine binds and not adrenergic receptors, but nicotinic receptors • Still part of ANS  Axons are likely myleinated  Adrenergic receptor sites  Beta 2 • When norepinephrine binds here get bronchodilation • Want to suck in as much oxygen as possible • Drugs will be used for bronchodilation in asthma  Alpha 1 • Primarily binds epinephrine or norephinephrine • Vasoconstrictor of vessels • Important in terms of hypertension • Result in vasodilation by decreasing binding o PNS  Calming nervous system  Acetylcholine  Muscarinic or nicotinic receptors that bind acetylcholine  SNS - Norepinephrine and Adrenergic  Parasympathetic nervous system – acetylcholine and muscarinic receptor sites  SNS o Stops digestion in favour of blood going to the limbs o Nervous system that you can think of as the  Exercise  Excitement  Emergency

 Embarrassment o Eyes – pupil dilation. Need to see better o Bronchodilation  Norepinephrine binding to beta 2 receptors o Heart  Uses norephinephrine binding to beta 1 receptors o Blood divereted to muscles o Decreased urine output o Increases sweating  PNS Resting and digesting Promotes squirting of glands Facilitates digestion Has to do with the  Digesting  Defecating  And dyuresis Each of the two nervous systems are subdivided into two other categories so that the drugs effect the SNS or PNS Sympathetic o Anticholinergic  Anitaceytlcholine  Block parasympathetic acetylcholine o Sympathomimetics  Mimics sympathetic nervous system  Promote sympathetic norepinephrine Parasympathetic o Cholinergic agonists  Agonists – promotes end result o Acetylcholinesterase inhibitors  Promotes the action of acetylcholine by keeping it in the synaptic space  esterase clean up enzymes Anticholinergics – sympathetic norepinephrine and adrenergic (muscarinic receptors) o Block the binding of acetylcholine at muscarinic sites o Block the intended parasympathetic effect of acetylcholine o Result is sympathetic o o Possible uses  Dilate pupils  Decreases urination, so may use it for incontinence  Contraindicated in benign prostatic HTN o Side effect o o o o

 





Facial flushing without sweating • Sweating controlled by acetylcholine not norepinepherine and these drugs block acetylcholine  Do not produce a euphoric state!!! o Atropine  Not specifically in the NPLEX blueprints, but works the same  Some impact at nicotinic sites at sweat glands that stop sweating  If someone takes too much of anticholenergic inhibitors then give them a shot of atropine to overcome that.  Antispasmotic • Sooth spasm in bronchi and GI  Envoking a sympathetic effect, so will stop disorders that have more blood fluid going to the area  Remember side effects • C/I o Peptic ulcers  Think that should use it for peptic ulcers, but need to look up why you don’t o Glaucoma  b/c cause pupil dilation  already have a problem with drainage and pressure  become more painful o Oxybutynin  Sympathetic reaction  antispasmodic reaction  not as strong as atropine, but has fewer side effects  has more of one action than the other  main use in MS induced incontinence  similar SE and C/I • important – gastric retention • Peptic ulcer o stops digestion, not an all or nothing response o people take these drugs and continue their ordinary lives with eating and drinking o if there is slow gastric emptying, people who have sluggish digestion it sits in their ST o in shifting their state to a sympathetic state the food, digestive juices, will keep everything in the ST and irritate an existing peptic ulcer  cleared through the LIV o Tolterodine  Similar to others 

 Muscarinic receptor antagonist  Cleared through LIV  Sympathomimetics o Symp, norepinepherine, adrenergic receptors o Catecholamines  Act directly at the SNS at adrenergic, alpha1/alpha2 or beta1/beta2  With LU • Bronchodilation  With HT • Increases rate and force of HT beat, so use for MI  Anapnyactic shock • SNS sending blood to vessels  Hypotension  Decongestions • Result is vasoconstriction that will dry up the nose  Norepinephrine is a potent vasoconstrictor  Side effect • Can produce a state of euphoria o Noncatecholamines  Methylphenidate • Blocks the reuptake of norepinephrine • Stays in synaptic space longer and does its thing longer • Don’t know why it calms overactive children down. • Similar to amphetamines • Side effect o MAOI  Results in certain hormones sticking in the synaptic space for longer  Careful using these with cyclic antidepressants   Amphetamines • Increase the release of those chemicals o Dopamine, norepinepheine • Block norepinephrine and potentially increasing the release of it • Used in ADHD o Mechanism of reaction in this disease is unknown o Seems counterintuitive, something that brings about a stimulative state in ADHD  Oxymetazoline • Visine or Dristan





Constriction of blood vessels leads to drainage, b/c not having continuous flow of blood and macrophage • Vasoconstriction allows the area to dry out • Other sympathomimetics are very addictive • When use too often becomes habit forming • C/I o If have HTN stay away from decongestants o BPH  Vasoconstriction  Will do all of the things that sympathomimetics will do too Psudoephedrine • Has peripheral effects (nasal decongestant) • Has some CNS effects that are expected with sympathomimetics, but less effect • Oral nasal decongestant • Review amphetamine SE as well • Look at the similarities of all these drugs • Figure out what are the key aspects

 Choliergic Agonist o PNS, acetylcholine and muscarinic receptors o Agonist – promotes something o Like sympathomimetics o Act at muscarinic receptors, and induce PNS effects o Used to induce calm relaxed state o Used to promote bladder function, digestion o PNS state, bronchoconstriction o Direct  Nicotine • Nicotinic agonist • When nicotine binds to nicotinic receptor it is stimulated • Binding of acetylcholine to nicotinic receptor is always stimulatory, but that doesn’t’ mean the body is stimulated. Overrides what normally happens • Acetylcholine binding to other sites either stimulates or activates or shuts down the receptor • First cigarette of the day causes the most profound reaction, with continued smoking throughout the day there is a steady stream of nicotine in the body o Indirect  Acetylcholinesterase Inhibitor • Block reuptake of acetycholine once it’s been released • Donepezil

o Parasympathetic effects o used in the treatment of early alzheimer’s disease and down syndrome o www.txtwriter.com/onscience/articles/addictingkids o give atropine of acetylcholinesterase poisoning o may also cause bladder outflow obstruction  Hypertension  Antihypertensives o Adrenergic blockers  Beta 1 and Beta 2 blocker • Propranolol o Used to treat migraines o Blocking beta 2 receptors that normally cause bronchodilation, so becomes a problem in asthmatics  Beta 1blockers • Used primarily in the treatment of HTN • Used to decrease HT rate and output, lowering pressure • At correct doses don’t have to worry about beta 2 blockage but at high doses you do • Atenolol and Metoprolol o Used in acute MI o Don’t use propranolol in an actue MI, b/c blocks delivery of Oxygen o At high doses A and M will inhibit beta 2 receptors o

Related Documents

Pharm Jan 18, 2007
November 2019 13
Syllubus 2007 Pharm
November 2019 3
Jan.18.
December 2019 11
Jan 2007
November 2019 42
Jan-2007
April 2020 19
Jan 2007
November 2019 29